27-Feb-2026
No headlines found.
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
ACCESS Newswire (Wed, 4-Feb 8:30 AM ET)
enVVeno Medical Announces Reverse Stock Split
ACCESS Newswire (Thu, 15-Jan 8:00 AM ET)
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Envveno Medical trades on the NASDAQ stock market under the symbol NVNO.
As of February 27, 2026, NVNO stock price declined to $10.00 with 10,368 million shares trading.
NVNO has a beta of 2.25, meaning it tends to be more sensitive to market movements. NVNO has a correlation of 0.05 to the broad based SPY ETF.
NVNO has a market cap of $6.55 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, NVNO traded as high as $243.95 and as low as $8.67.
The top ETF exchange traded funds that NVNO belongs to (by Net Assets): VXF, IWC.
NVNO has underperformed the market in the last year with a return of -91.9%, while the SPY ETF gained +18.5%. In the last 3 month period, NVNO fell short of the market, returning -16.0%, while SPY returned +1.2%. However, in the most recent 2 weeks NVNO has outperformed the stock market by returning +7.2%, while SPY returned +0.6%.
NVNO support price is $9.38 and resistance is $11.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVNO shares will trade within this expected range on the day.